International Clinical Trial: A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07309445) titled 'A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States' on Dec. 16, 2025.

Study Type: Observational

Primary Sponsor: Janssen Research & Development, LLC

Condition: Non-Muscle Invasive Bladder Neoplasms

Recruitment Status: Not recruiting

Date of First Enrollment: December 18, 2025

Target Sample Size: 150

To know more, visit https://clinicaltrials.gov/study/NCT07309445

Published by HT Digital Content Services with permission from Health Daily Digest....